Back to results
TerminatedPhase 1

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

NCT05069935

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hackensack University Medical Center

Hackensack, New Jersey, United States

+3 additional locations

View on ClinicalTrials.gov
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors — TrialFind